Please login to the form below

Not currently logged in
Email:
Password:

Cardio3 BioSciences appoints Warren Sherman chief medical officer

He joins the biopharma firm from Columbia University Medical Center

edit-C3BS_Dr-Warren-ShermanBelgian biopharma firm Cardio3 BioSciences has named Warren Sherman as its chief medical officer.

Sherman has over 30 years' cardiology experience, with a focus on cell-based therapies for treating patients post-myocardial infarction and with heart failure.

He will assume the role at the cardiovascular disease-focused company from November 1.

He joins from Columbia University Medical Center, where he served in numerous roles including director of stem cell research and regenerative medicine and interventional cardiologist.

Sherman said: “I am thrilled to be joining Cardio3 BioSciences as chief medical officer at such an exciting time in its clinical development phase.

“The accomplishments of this young and dynamic company are remarkable, and it is an enormous opportunity for me to be part of the most promising project in the fields of cell therapy and other treatments for cardiovascular diseases.”

Sherman is also founder of the Cardiovascular Research Foundation's international conference on cell therapy for cardiovascular disease (IC3D), a meeting for healthcare experts dedicated to the evolving file of cell-based therapies for the repair and regeneration of cardiac and vascular disease.

Christian Homsy, CEO of Cardio3 BioSciences, added: “We are very pleased to be able to count on Warren Sherman's expertise in clinical application, as well as his renowned scientific outreach for the further development of Cardio3 BioSciences' future projects in regenerative therapies and cardiovascular diseases.”

3rd November 2014

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics